Decoding complex disease through multiomics
)
- Published on:
Complex diseases are shaped by polygenic risk, regulatory variation, and molecular mechanisms that cannot be fully explained by single-omics approaches.
In this webinar, our expert speakers discuss how multiomic Oxford Nanopore sequencing supports a deeper understanding of disease mechanisms, by integrating DNA, RNA, and epigenetic analysis — all on a single platform.
You will learn:
- How multiomic Oxford Nanopore sequencing brings together characterisation of DNA variants, RNA isoforms, and DNA and RNA modifications for more comprehensive disease research.
- How multiomic insights can support biomarker discovery and translational research into neurodegenerative conditions such as Alzheimer’s disease.
- How Oxford Nanopore is unlocking new possibilities in RNA and cDNA sequencing, with a new cDNA-PCR protocol generating longer, more complete reads and more accurate isoform resolution than legacy technologies.
